ferrocene carbamate has been researched along with iminoquinone in 1 studies
| Studies (ferrocene carbamate) | Trials (ferrocene carbamate) | Recent Studies (post-2010) (ferrocene carbamate) | Studies (iminoquinone) | Trials (iminoquinone) | Recent Studies (post-2010) (iminoquinone) |
|---|---|---|---|---|---|
| 5 | 0 | 2 | 30 | 0 | 16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hagen, H; Hofer, W; Kinski, E; Knaup, KX; Marzenell, P; Meyer, K; Mokhir, A; Raskatov, JA; Zolnhofer, EM | 1 |
1 other study(ies) available for ferrocene carbamate and iminoquinone
| Article | Year |
|---|---|
4-Azidobenzyl ferrocenylcarbamate as an anticancer prodrug activated under reductive conditions.
Topics: Antineoplastic Agents; Azides; Cell Death; Cell Line, Tumor; Cell Survival; Ferrous Compounds; Glutathione; HL-60 Cells; Humans; Hydrogen Peroxide; Indolequinones; Inhibitory Concentration 50; Iron; Metallocenes; Oxidation-Reduction; Oxidative Stress; Prodrugs; Quinones | 2016 |